![Bradley J Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Bradley J Glass is currently Director at Quest PharmaTech, Inc. and Director at Resverlogix Corp.
starting in 2025.
Formerly, Mr. Glass was General Counsel at Hepalink USA, Inc. Education includes undergraduate studies at Wabash College and graduate studies at Indiana University Maurer School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/08/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| QUEST PHARMATECH INC. | Director/Miembro de la Junta | - |
| RESVERLOGIX CORP. | Director/Miembro de la Junta | 18/11/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Hepalink USA, Inc.
 Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Resverlogix Corp.
 Resverlogix Corp. Pharmaceuticals: MajorHealth Technology Engages in the research and development of novel biopharmaceuticals for the treatment of grievous diseases | Health Technology |
Quest PharmaTech, Inc.
 Quest PharmaTech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pharmaceutical products for the treatment of cancer | Commercial Services |
Wabash College
 Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University Maurer School of Law
 Indiana University Maurer School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
